CCM
FLXN

Convector Capital Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Convector Capital Management’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$305K Sell
15,617
-8,383
-35% -$142K 0.56% 28
2016
Q2 		$359K Buy
+24,000
New +$302K 0.5% 30

Other funds holding FLXN

GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Convector Capital Management's FLXN Position: Q3 2016 in Review

Convector Capital Management reduced its Flexion Therapeutics, Inc. (FLXN) stake by 35% in Q3 2016, selling an estimated $142K and leaving 15,617 shares worth $305K. The position accounts for 0.56% of the portfolio, ranked #28.

Convector Capital Management first reported a position in FLXN in Q2 2016 and has held it in 2 quarters since. The position peaked at $359K in Q2 2016. 84 funds tracked by Wall St. Rank hold FLXN as of Q3 2016.

  • Convector Capital Management held 15,617 shares of Flexion Therapeutics, Inc. worth $305K as of Q3 2016.
  • Convector Capital Management sold 8,383 Flexion Therapeutics, Inc. shares in Q3 2016, an estimated $142K.
  • Flexion Therapeutics, Inc. made up 0.56% of Convector Capital Management's portfolio in Q3 2016, its #28 holding.
  • Convector Capital Management first reported a position in Flexion Therapeutics, Inc. in Q2 2016 and has held it in 2 quarters since.
  • Convector Capital Management's Flexion Therapeutics, Inc. position peaked at $359K in Q2 2016.
  • 84 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q3 2016.

Based on Convector Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.